The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

Nov. 19, 2018
Applicant:

Rapt Therapeutics, Inc., South San Francisco, CA (US);

Inventors:

Hilary Plake Beck, Emerald Hills, CA (US);

Berenger Biannic, San Mateo, CA (US);

Minna Hue Thanh Bui, Oakland, CA (US);

Dennis X. Hu, San Mateo, CA (US);

John Michael Ketcham, San Mateo, CA (US);

Jay Patrick Powers, Pacifica, CA (US);

Maureen Kay Reilly, San Francisco, CA (US);

Omar Robles-Resendiz, Redwood City, CA (US);

Hunter Paul Shunatona, San Francisco, CA (US);

James Ross Walker, Verona, WI (US);

David Juergen Wustrow, Los Gatos, CA (US);

Ashkaan Younai, San Francisco, CA (US);

Mikhail Zibinsky, Redwood City, CA (US);

Jeffrey J. Jackson, San Bruno, CA (US);

Assignee:

RAPT THERAPEUTICS, INC., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); A61K 31/5377 (2006.01); A61K 31/454 (2006.01); A61K 31/122 (2006.01); A61K 31/593 (2006.01); A61K 31/519 (2006.01); A61K 31/42 (2006.01); A61K 31/4706 (2006.01); A61K 31/198 (2006.01); A61K 31/7135 (2006.01); A61K 31/235 (2006.01); A61K 31/728 (2006.01); C07D 487/04 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/122 (2013.01); A61K 31/198 (2013.01); A61K 31/235 (2013.01); A61K 31/42 (2013.01); A61K 31/454 (2013.01); A61K 31/4706 (2013.01); A61K 31/4985 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/593 (2013.01); A61K 31/7135 (2013.01); A61K 31/728 (2013.01); A61K 45/06 (2013.01);
Abstract

Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of CCR4 activity.


Find Patent Forward Citations

Loading…